GPIIb/IIIa PET/CT Imaging for Thrombi in the Brain and Body

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the safety and diagnostic performance of 18F/68Ga-GP1 PET imaging for detecting thrombi in adults. The approach uses a small molecule tracer that targets GPIIb/IIIa receptors to visualize thrombi with PET/CT. Eligible participants may have suspected, newly diagnosed, or previously treated thrombi and are scheduled for GPIIb/IIIa PET/CT imaging. The study is conducted at multiple Chinese centers led by Tianjin Medical University with collaborations at affiliated hospitals. Outcomes focus on safety and how well GP1 PET imaging can detect thrombi compared with standard imaging.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated thrombi (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled GPIIb/IIIa PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.

Exclusion Criteria:

* (i) patients with non-thrombi lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

Where it's running

• The First Affiliated Hospital of University of Science and Technology of China
  Hefei, Anhui, China Recruiting
• The Affiliated Hospital of Qingdao University
  Qingdao, Shandong, China Recruiting
• Tianjin Medical University General Hospital
  Tianjin, Tianjin Municipality, China Recruiting

Study contacts

• Study coordinator: Haonan Yu, MD
• Email: dreamadam@126.com
• Phone: +8613821000597

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding heart artery disease using biomarkers and imaging in Oxford

  Researchers in Oxford are testing how biomarkers and advanced imaging can help explain why some heart artery plaques are unstable and how this affects heart damage after a heart attack.

  Recruiting University of Oxford · Oxford · NCT07772570

• Imaging and analyzing blood clots in the brain

  This study is testing how brain imaging of blood clots can help doctors understand treatment outcomes for patients with blocked arteries in the brain and neck.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT05663281

• Confirming the safety and performance of TufTex Embolectomy Catheters

  This study is testing a new type of catheter to see if it safely and effectively removes blood clots from arteries in people who are having surgery.

  Recruiting at 2 sites LeMaitre Vascular · Brandenburg and 2 other locations · NCT05386342

• Apixaban vs Warfarin for a Left Ventricular Thrombus

  This study tests whether apixaban can more conveniently and safely dissolve a left ventricular blood clot compared with warfarin.

  Recruiting Phase 3 University of Arizona · Tucson, Arizona · NCT07709780

• Registry for patients with left ventricular thrombus

  This study is gathering information from people with blood clots in the heart to better understand the condition and improve treatment options.

  Recruiting at 5 sites Queen Mary University of London · Cambridge, Cambridgeshire and 7 other locations · NCT06963567

• Using Apixaban to prevent blood clots after heart attacks

  This study is testing if a low dose of Apixaban can help prevent blood clots in people who have had a heart attack and have weak heart function.

  Recruiting Phase 3 National Institute of Cardiovascular Diseases, Pakistan · Karachi, Sindh · NCT06742567

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.